Selected research
Industry Growth & Trends
Global Swine Circovirus Vaccine Industry Growth and Trends Forecast to 2032
Market perspective
The global Swine Circovirus Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Swine Circovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Swine Circovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Swine Circovirus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Swine Circovirus Vaccine include Boehringer Ingelheim, CAVAC, Chopper Biology, DHN, Komipharm, Ringpu Biology, Zoetis, ChengDu Tecbond and Jinyu Bio-Technology, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Swine Circovirus Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Swine Circovirus Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Swine Circovirus Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Swine Circovirus Vaccine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Swine Circovirus Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Swine Circovirus Vaccine Market by Company
Boehringer Ingelheim
CAVAC
Chopper Biology
DHN
Komipharm
Ringpu Biology
Zoetis
ChengDu Tecbond
Jinyu Bio-Technology
Qilu Animal
Swine Circovirus Vaccine Segment by Type
Genetic Engineering Vaccine
Killed Vaccines
Swine Circovirus Vaccine Segment by Application
Piglets
Adults Pigs
Swine Circovirus Vaccine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Swine Circovirus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Swine Circovirus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Swine Circovirus Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Swine Circovirus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Swine Circovirus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Genetic Engineering Vaccine
- Killed Vaccines
Applications
- Piglets
- Adults Pigs
Companies covered
- Boehringer Ingelheim
- CAVAC
- Chopper Biology
- DHN
- Komipharm
- Ringpu Biology
- Zoetis
- ChengDu Tecbond
- Jinyu Bio-Technology
- Qilu Animal
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Swine Circovirus Vaccine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Swine Circovirus Vaccine Sales Estimates and Forecasts (2021-2032)
- 1.3 Swine Circovirus Vaccine Market by Type
- 1.3.1 Genetic Engineering Vaccine
- 1.3.2 Killed Vaccines
- 1.4 Global Swine Circovirus Vaccine Market Size by Type
- 1.4.1 Global Swine Circovirus Vaccine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Swine Circovirus Vaccine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Swine Circovirus Vaccine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Swine Circovirus Vaccine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Swine Circovirus Vaccine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Swine Circovirus Vaccine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Swine Circovirus Vaccine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Swine Circovirus Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Swine Circovirus Vaccine Industry Trends
- 2.2 Swine Circovirus Vaccine Industry Drivers
- 2.3 Swine Circovirus Vaccine Industry Opportunities and Challenges
- 2.4 Swine Circovirus Vaccine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Swine Circovirus Vaccine Revenue (2021-2026)
- 3.2 Global Top Players by Swine Circovirus Vaccine Sales (2021-2026)
- 3.3 Global Top Players by Swine Circovirus Vaccine Price (2021-2026)
- 3.4 Global Swine Circovirus Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Swine Circovirus Vaccine Major Company Production Sites & Headquarters
- 3.6 Global Swine Circovirus Vaccine Company, Product Type & Application
- 3.7 Global Swine Circovirus Vaccine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Swine Circovirus Vaccine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Swine Circovirus Vaccine Players Market Share by Revenue in 2025
- 3.8.3 2025 Swine Circovirus Vaccine Tier 1, Tier 2, and Tier 3
4 Swine Circovirus Vaccine Regional Status and Outlook
- 4.1 Global Swine Circovirus Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Swine Circovirus Vaccine Historic Market Size by Region
- 4.2.1 Global Swine Circovirus Vaccine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Swine Circovirus Vaccine Sales in Value by Region (2021-2026)
- 4.2.3 Global Swine Circovirus Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Swine Circovirus Vaccine Forecasted Market Size by Region
- 4.3.1 Global Swine Circovirus Vaccine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Swine Circovirus Vaccine Sales in Value by Region (2027-2032)
- 4.3.3 Global Swine Circovirus Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Swine Circovirus Vaccine by Application
- 5.1 Swine Circovirus Vaccine Market by Application
- 5.1.1 Piglets
- 5.1.2 Adults Pigs
- 5.2 Global Swine Circovirus Vaccine Market Size by Application
- 5.2.1 Global Swine Circovirus Vaccine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Swine Circovirus Vaccine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Swine Circovirus Vaccine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Swine Circovirus Vaccine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Swine Circovirus Vaccine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Swine Circovirus Vaccine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Swine Circovirus Vaccine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Swine Circovirus Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Boehringer Ingelheim
- 6.1.1 Boehringer Ingelheim Company Information
- 6.1.2 Boehringer Ingelheim Business Overview
- 6.1.3 Boehringer Ingelheim Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Boehringer Ingelheim Swine Circovirus Vaccine Product Portfolio
- 6.1.5 Boehringer Ingelheim Recent Developments
- 6.2 CAVAC
- 6.2.1 CAVAC Company Information
- 6.2.2 CAVAC Business Overview
- 6.2.3 CAVAC Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 CAVAC Swine Circovirus Vaccine Product Portfolio
- 6.2.5 CAVAC Recent Developments
- 6.3 Chopper Biology
- 6.3.1 Chopper Biology Company Information
- 6.3.2 Chopper Biology Business Overview
- 6.3.3 Chopper Biology Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Chopper Biology Swine Circovirus Vaccine Product Portfolio
- 6.3.5 Chopper Biology Recent Developments
- 6.4 DHN
- 6.4.1 DHN Company Information
- 6.4.2 DHN Business Overview
- 6.4.3 DHN Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 DHN Swine Circovirus Vaccine Product Portfolio
- 6.4.5 DHN Recent Developments
- 6.5 Komipharm
- 6.5.1 Komipharm Company Information
- 6.5.2 Komipharm Business Overview
- 6.5.3 Komipharm Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Komipharm Swine Circovirus Vaccine Product Portfolio
- 6.5.5 Komipharm Recent Developments
- 6.6 Ringpu Biology
- 6.6.1 Ringpu Biology Company Information
- 6.6.2 Ringpu Biology Business Overview
- 6.6.3 Ringpu Biology Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Ringpu Biology Swine Circovirus Vaccine Product Portfolio
- 6.6.5 Ringpu Biology Recent Developments
- 6.7 Zoetis
- 6.7.1 Zoetis Company Information
- 6.7.2 Zoetis Business Overview
- 6.7.3 Zoetis Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Zoetis Swine Circovirus Vaccine Product Portfolio
- 6.7.5 Zoetis Recent Developments
- 6.8 ChengDu Tecbond
- 6.8.1 ChengDu Tecbond Company Information
- 6.8.2 ChengDu Tecbond Business Overview
- 6.8.3 ChengDu Tecbond Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 ChengDu Tecbond Swine Circovirus Vaccine Product Portfolio
- 6.8.5 ChengDu Tecbond Recent Developments
- 6.9 Jinyu Bio-Technology
- 6.9.1 Jinyu Bio-Technology Company Information
- 6.9.2 Jinyu Bio-Technology Business Overview
- 6.9.3 Jinyu Bio-Technology Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Jinyu Bio-Technology Swine Circovirus Vaccine Product Portfolio
- 6.9.5 Jinyu Bio-Technology Recent Developments
- 6.10 Qilu Animal
- 6.10.1 Qilu Animal Company Information
- 6.10.2 Qilu Animal Business Overview
- 6.10.3 Qilu Animal Swine Circovirus Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Qilu Animal Swine Circovirus Vaccine Product Portfolio
- 6.10.5 Qilu Animal Recent Developments
7 North America by Country
- 7.1 North America Swine Circovirus Vaccine Sales by Country
- 7.1.1 North America Swine Circovirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Swine Circovirus Vaccine Sales by Country (2021-2026)
- 7.1.3 North America Swine Circovirus Vaccine Sales Forecast by Country (2027-2032)
- 7.2 North America Swine Circovirus Vaccine Market Size by Country
- 7.2.1 North America Swine Circovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Swine Circovirus Vaccine Market Size by Country (2021-2026)
- 7.2.3 North America Swine Circovirus Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Swine Circovirus Vaccine Sales by Country
- 8.1.1 Europe Swine Circovirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Swine Circovirus Vaccine Sales by Country (2021-2026)
- 8.1.3 Europe Swine Circovirus Vaccine Sales Forecast by Country (2027-2032)
- 8.2 Europe Swine Circovirus Vaccine Market Size by Country
- 8.2.1 Europe Swine Circovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Swine Circovirus Vaccine Market Size by Country (2021-2026)
- 8.2.3 Europe Swine Circovirus Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Swine Circovirus Vaccine Sales by Country
- 9.1.1 Asia-Pacific Swine Circovirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Swine Circovirus Vaccine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Swine Circovirus Vaccine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Swine Circovirus Vaccine Market Size by Country
- 9.2.1 Asia-Pacific Swine Circovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Swine Circovirus Vaccine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Swine Circovirus Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Swine Circovirus Vaccine Sales by Country
- 10.1.1 South America Swine Circovirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Swine Circovirus Vaccine Sales by Country (2021-2026)
- 10.1.3 South America Swine Circovirus Vaccine Sales Forecast by Country (2027-2032)
- 10.2 South America Swine Circovirus Vaccine Market Size by Country
- 10.2.1 South America Swine Circovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Swine Circovirus Vaccine Market Size by Country (2021-2026)
- 10.2.3 South America Swine Circovirus Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Swine Circovirus Vaccine Sales by Country
- 11.1.1 Middle East and Africa Swine Circovirus Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Swine Circovirus Vaccine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Swine Circovirus Vaccine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Swine Circovirus Vaccine Market Size by Country
- 11.2.1 Middle East and Africa Swine Circovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Swine Circovirus Vaccine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Swine Circovirus Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Swine Circovirus Vaccine Value Chain Analysis
- 12.1.1 Swine Circovirus Vaccine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Swine Circovirus Vaccine Production Mode & Process
- 12.2 Swine Circovirus Vaccine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Swine Circovirus Vaccine Distributors
- 12.2.3 Swine Circovirus Vaccine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst